Also available in Persian — نسخه فارسی ✈️ Telegram EN فا
ISNA is a semi-official Iranian news agency (Iranian Students News Agency). This is a translation of that outlet's own report; it is the outlet's account, not Artesh's finding. See what Iranian state media is saying today.
❓ Unknown

The Economic Burden of Alzheimer's in the Country is 20 Trillion Tomans / 2 Trillion Tomans Savings with Targeted Research

2w ago October 28, 2026 1 min read 📰 ISNA
📋 Key Takeaway

The economic burden of Alzheimer's disease in Iran is estimated at 20 trillion tomans annually. Targeted research and early intervention could potentially save the country about 2 trillion tomans each year. This highlights the importance of investing in healthcare research to alleviate economic pressures.

🔍 Quick Context Guide
💡 Bottom Line: Investing in targeted research for Alzheimer's could lead to significant economic savings and better health outcomes in Iran.

👥 Key Players

Secretary of the Cognitive Sciences and Technologies Development Headquarters MENTIONED
Government official overseeing cognitive health initiatives
"They play a crucial role in shaping health policy and research funding related to cognitive diseases in Iran."

📰 What Happened

The Secretary of the Cognitive Sciences and Technologies Development Headquarters announced that the annual economic burden of Alzheimer's disease in Iran is 20 trillion tomans. They emphasized that targeted research and early intervention could save the country 2 trillion tomans each year.

  • The economic burden of Alzheimer's in Iran is estimated at 20 trillion tomans annually.
  • A 10% reduction in this burden through research could save approximately 2 trillion tomans.

💡 Why It Matters

🇮🇷 For Iran: Reducing the economic burden of Alzheimer's could free up resources for other healthcare needs and improve quality of life for patients and families.
🌍 Regional: Improved healthcare research in Iran could serve as a model for other countries in the region facing similar health challenges.
🌐 International: Internationally, advancements in Iranian healthcare research could attract foreign investment and collaboration in medical fields.

📚 Background

Alzheimer's disease is a growing concern globally, and its economic impact is particularly pronounced in countries with aging populations like Iran. Effective management and research are essential for mitigating these costs.

Aging population in Iran Healthcare funding and policy in Iran
📡 Source: STATE MEDIA
📊 Confidence: 70%
This source is likely to reflect government priorities and may emphasize the need for increased funding in healthcare research.

The Secretary of the Cognitive Sciences and Technologies Development Headquarters pointed out that the annual economic burden of Alzheimer's disease in the country is estimated at 20 trillion tomans. He stated that if targeted research and actions such as timely diagnosis and early intervention can reduce the economic burden of this disease by 10 percent, approximately 2 trillion tomans would be saved annually in direct and indirect costs.

🏷️ Entities Mentioned

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 85%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →